Program

09:00–09:30 Alzheimer's disease and the Rotterdam Study
Prof. Arfan Ikram, Erasmus MC, Rotterdam, the Netherlands
09:30–10:00 Proteomics and clinical applications
Prof. Matthias Mann, Max Planck Institute, Martinsried (Munich), Germany
10:00–10:30 Coffee break
10:30–11:00 COPD, the need for biomarkers
Prof. Guy Brusselle, University of Ghent, Belgium
11:00–11:30 Technical advances in proteomics
Prof. Gyorgy Marko–Varga, Lund University, Sweden
11:30–12:00 Biomarkers for Diabetes
Dr. Tomas Jelenik, Heinrich Heine University Düsseldorf, Germany
12:00–12:30 Metabolics towards personalised medicine
Prof. Ron Wevers, Radboud UMC, Nijmegen, the Netherlands
12:30–14:00 Posters and satellite sessions about various technologies
Lunch
14:00–14:30 Biomarker Development Center
Prof. Alain van Gool, Radboud UMC, Nijmegen, the Netherlands
14:30–15:00 Combining proteomics and systems biology to identify biomarkers and therapeutic targets
Dr. Antonia Vlahou, BRFAA, Athens, Greece
15:00–15:30 Guidelines for biomarker validation
John Allinson, LGC, Fordham, United Kingdom
15:30–16:00 How to bridge morphology and molecular markers in COPD and pulmonary fibrosis
Dr. Jan von der Thüsen, Erasmus MC, Rotterdam, the Netherlands
16:00–16:30Tea break
16:30–17:00 Biomarker development and clinical implementation, an example
Prof. Harald Mischak, University of Glasgow, United Kingdom/Mosaiques Diagnostics, Hannover, Germany
17:00–18:00Discussion, closing and reception



––>